Journal of International Society of Nephrology Publishes Supplement Containing State-of-the-Art Data on Albuminuria.NEW YORK -- Research at First-of-Its-Kind Conference Indicates that Albuminuria albuminuria /al·bu·min·uria/ (al-bu?mi-nu´re-ah) presence in the urine of serum albumin, the most common kind of proteinuria.albuminu´ric al·bu·mi·nu·ri·a n. is an Independent Risk Marker for All Patients and is a Therapy Target for Kidney and Cardiovascular Disease The November supplement to the International Society of Nephrology's Journal, Kidney International, contains data presented at the International Symposium of Albuminuria in New York last May. The supplement titled "Albuminuria: Risk Marker and Target for Treatment" includes a broad array of research on the protein's predictive power as a risk marker and therapy target, its mechanism of action, and advances in how it is measured. The results illustrate that albuminuria is an independent risk marker for kidney and cardiovascular disease not only in at-risk patients such as diabetics but also in the general population. Initial data also suggests that albuminuria can serve as an independent therapy target, irrespective of cholesterol, blood pressure and other commonly used drug efficacy parameters. Highlights of additional research presented in the supplement include: --Microalbuminuria is associated with significant glomerular glomerular /glo·mer·u·lar/ (glo-mer´u-ler) pertaining to or of the nature of a glomerulus, especially a renal glomerulus. glo·mer·u·lar adj. pathology and increased renal as well as cardiovascular risk (Mogensen et al., S-41). --Measurement of urinary albumin - before starting and during treatment - may be a useful tool to identify both diabetic and nondiabetic patients at high risk of renal and cardiovascular disease (Mann et al., S-61). --Combining the level of urinary albumin to the Framingham score results in a highly efficient primary prevention strategy (Asselbergs et al., S-113). --Clinical trial results suggest that HPLC HPLC high-performance liquid chromatography. HPLC high performance liquid chromatography. HPLC High-performance liquid chromatography Lab instrumentation A highly sensitive analytic method in which analytes are placed techniques identify more people at risk especially when screening large populations (Brinkman et al., S-75). "The data in the supplement overwhelmingly proves that excess albumin indicates risk for kidney and cardiovascular disease. We also know that commonly available drugs such as ACE-inhibitors and Angiotensin II Receptor Blockers (ARBS) may lower albumin levels by as much as 40 percent. The most significant remaining question is, does a reduction in albumin levels result in protection against disease?" said Symposium Chair and Supplement Guest Editor Dr. Dick de Zeeuw, who is also Professor and Head of the Department of Clinical Pharmacology at the University Medical Center of Groningen in the Netherlands. "Initial data is indicating this is the case, but more research needs to be done. The intention is that during the follow-up conference, researchers will present results from additional intervention trials addressing this question. I feel strongly that as more results come in, the medical community will begin targeting albumin for reduction if abnormally high, just like with blood pressure and cholesterol. Future trials may also indicate that everyone - not just those at risk - should be tested for albuminuria regularly." The follow-up conference is scheduled for 2005 in Europe, with the goal of establishing clear guidelines regarding the value of albumin in the clinic. In an introductory letter in the supplement, Guest Editors Drs. de Zeeuw, Marc Pfeffer and George Bakris explain that this upcoming conference will also discuss how and when the medical community should measure urinary albumin, and how albuminuria compares to glomerular filtration rate glomerular filtration rate n. Abbr. GFR The volume of water filtered out of the plasma through glomerular capillary walls into Bowman's capsules per unit of time. as a cardiovascular risk marker. The May event was organized by the National Kidney Foundation Not to be confused with American Kidney Fund. The National Kidney Foundation, Inc. (NKF) is a major voluntary health organization in the United States. Its mission is to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and and International Society of Nephrology nephrology Branch of medicine dealing with kidney function and diseases. An understanding of kidney physiology is important not only in treating kidney disease but in knowing the effect of drugs, diet, and hypertension on kidney disease, and vice versa. , and was supported by the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of , American Society of Hypertension, American Society of Nephrology, European Society of Hypertension The European Society of Hypertension (ESH) is an international organization with objectiive to provide a stable and organized European platform for scientific exchange in hypertension. Was created in 1989 on initiative of prof. Alberto Zanchetti. , International Diabetes Federation The International Diabetes Federation (IDF) is a worldwide alliance of 200 diabetes associations in more than 150 countries, who have come together to enhance the lives of people with diabetes everywhere. For over 50 years, IDF has been at the vanguard of global diabetes advocacy. , Juvenile Diabetes Research Foundation The Juvenile Diabetes Research Foundation (JDRF) is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. and the following councils of the American Heart Association American Heart Association (AHA), n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities. : Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on High Blood Pressure Research, and the Council on Kidney in Cardiovascular Disease. The Symposium was made possible by an educational grant by AusAm Biotechnologies, Inc. About the National Kidney Foundation The National Kidney Foundation is a major voluntary health organization which seeks to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation. About the International Society of Nephrology The International Society of Nephrology (ISN Noun 1. ISN - Switzerland's information network for security and defense studies and for peace and conflict research and for international relations International Relations and Security Network ) is committed to the worldwide advancement of education, science and patient care in nephrology. This goal is achieved by means of the Society's journal, the organization of international congresses and symposia, and various outreach programs around the world. The ISN acts as an international forum on nephrology for leading nephrologists as well as young investigators, from both developed and emerging countries. In view of the escalating problem of global kidney disease, the ISN has further adopted a mission of prevention and regression of chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is . Further information is available at www.isn-online.org. About AusAm AusAm Biotechnologies, Inc. is a biotechnology research and development company commercializing both diagnostic and therapeutic products to identify and treat major diseases. Accumin(TM), AusAm's FDA-cleared diagnostic for the detection of intact albumin in urine, is the first direct test to measure a potential indicator of the beginning stages of kidney disease and it is currently offered by several reference laboratories and hospitals in the United States Lists of hospitals for each U.S. state:
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion